Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,063 JPY | -0.37% | -3.63% | -15.84% |
05/06 | Japan Lifeline Completes 5.23 Billion Yen Share Acquisition via Tender Offer | MT |
04/06 | Tranche Update on Japan Lifeline Co., Ltd.'s Equity Buyback Plan announced on May 1, 2024. | CI |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The group's high margin levels account for strong profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- With a P/E ratio at 10.14 for the current year and 9.22 for next year, earnings multiples are highly attractive compared with competitors.
- For the last twelve months, analysts have been gradually revising upwards their EPS forecast for the upcoming fiscal year.
- Analysts remain confident with respect to the group's activity and, more often than not, have revised upwards their earnings per share estimates.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- With relatively low growth outlooks, the group is not among those with the highest revenue growth potential.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- Over the past twelve months, analysts' opinions have been revised negatively.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-15.84% | 507M | - | ||
+15.11% | 131B | A- | ||
-8.24% | 10.92B | A- | ||
-11.46% | 7.72B | C | ||
+40.89% | 5.64B | B+ | ||
-19.54% | 4.86B | C | ||
+8.12% | 3.43B | C- | ||
-19.67% | 2.47B | B- | ||
-15.68% | 1.98B | - | ||
-15.34% | 1.88B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 7575 Stock
- Ratings Japan Lifeline Co., Ltd.